Sign in
Taking people in United StatesNo phase

Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches

Key facts

Who runs it
Veterans Medical Research Foundation
Where
San Diego, United StatesSee the site
Trial code
Status
Recruiting
People taking part
240 people, planned
Started
1 Jan 2022
Planned end
31 Aug 2025
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Active rTMS
  • Headache Management Therapy
  • Sham rTMS
  • Headache Education Control
Record updated
21 November 2024

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Mild Traumatic Brain Injury (mTBI)
  • Chronic headaches > 3 months after injury
  • Aged 18-65
  • No prior TMS treatment
  • Persistent Headaches with an intensity > 30 / 100
  • No history of daily headache prior to mTBI

Who cannot take part

  • History of chronic headache like migraine prior to mTBI
  • Evidence in chart of exacerbation of depressive/anxiety symptoms, active substance dependence, suicidal intent or attempt within previous month
  • History of dementia or major psychiatric disease, such as bipolar disorder or schizophrenia
  • History of seizure
  • Pregnant
  • Pacemaker or any metal in body that would prevent MRI
  • Presence of any other chronic neuropathic pain states
  • Pending litigation
  • Can't understand English

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial is currently available in United States.

  • VA San Diego Healthcare SystemSan Diego, United StatesContact: Caleb Lopez, BSTaking people

About the trial

What the trial wants to find out

This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild traumatic brain injury (mTBI) related headaches. The investigators hypothesize that active rTMS combined with telehealth therapy will provide marked reduction in mTBI related headaches and symptoms in comparison to their placebo counterparts.

The 4 groups in the trial

  • Active rTMS with telehealth headache management therapyExisting treatment, for comparison

    Participants receive both active rTMS treatment at the left dorsolateral prefrontal cortex and therapy for headache management

    Treatment: Active rTMS and Headache Management Therapy

  • Active rTMS with telehealth headache education controlOther group

    Participants receive active rTMS treatment at the left dorsolateral prefrontal cortex and headache education

    Treatment: Active rTMS and Headache Education Control

  • Sham rTMS with telehealth headache management therapyOther group

    Participants receive sham rTMS treatment at the left dorsolateral prefrontal cortex and therapy for headache management

    Treatment: Headache Management Therapy and Sham rTMS

  • Sham rTMS with telehealth headache education controlSham treatment, for comparison

    Participants receive sham rTMS treatment at the left dorsolateral prefrontal cortex and headache education

    Treatment: Sham rTMS and Headache Education Control

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Combined Nonpharmacological Therapies for MTBI-Related Headaches
Criteria questions
Built from NCT05176392, who can take part
Record updated
21 November 2024